Equity Overview
Price & Market Data
Price: $0.529
Daily Change: +$0.0215 / 4.06%
Daily Range: $0.482 - $0.54
Market Cap: $6,755,778
Daily Volume: 190,339
Performance Metrics
1 Week: 14.73%
1 Month: 15.05%
3 Months: -58.48%
6 Months: -66.47%
1 Year: -84.71%
YTD: -51.80%
Company Details
Employees: 13
Sector: Health technology
Industry: Biotechnology
Country: Germany
Details
Mainz Biomed N.V. develops and sells in-vitro diagnostic (IVD) tests for the early detection of cancer in the United States and Europe. It offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. The company also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. In addition, it operates a clinical diagnostic laboratory; and distributes its IVD kits to third-party laboratories. The company has a collaboration agreement with Thermo Fisher Scientific Inc. for the development and commercialization of colorectal cancer screening product. Mainz Biomed N.V. was founded in 2008 and is based in Mainz, Germany.